Importantly, tumors containing mutations in HR genes, MMR genes, or POLE contained significantly higher mutational load than DNA repair wildtype tumors, and similarly contained significantly increased infiltration by many of the T cell types and other immune cells desirable for anti-tumor activity. The gene discussed is MRC1; the disease is neoplasm.